Hypertension Treatments: Diuretics
A comparative list of loop, potassium-sparing, and thiazide-like diuretics monotherapy and combination therapy for the treatment of hypertension.
Cardiovascular Disease
Anticoagulant Dosing Conversions
Recommended dosing conversions for anticoagulants such as warfarin, heparin, and dabigatran.
AHA: Cardiovascular Risk Factors Tied to Increased Cancer Risk
Risk for subsequent cancer up with development of interim CV events, including heart failure, MI.
Hypertension Treatments: Oral CCBs
Oral calcium channel blockers (CCBs) for the treatment of hypertension including benzothiazepines, dihydropyridines, and diphenylalkylamines.
Hypertension Treatments: ARBs
A comparative list of Angiotensin II Receptor Blockers (ARBs) monotherapy and combination therapy for the treatment of hypertension.
Thromboembolic Disorder Treatments
Anticoagulants, antiplatelets, and thrombolytics for the treatment and/or prophylaxis of venous and arterial thrombosis.
VTE Risk and Incidence in Hospitalized Patients With Blood Cancers
A new study aims to address the conundrum of coagulation risk in patients hospitalized for hematologic malignancies.
Prediagnosis Exercise May Reduce CV Risk in Breast Cancer
Incidence of composite cardiovascular events decreased across increasing total MET hours/week.
Dyslipidemia Drug Indications
Comparative chart of single and combination treatment options indicating which lipids can be targeted for dyslipidemias.
Cancer Risk From Recalled ARBs “Likely Much Lower” Than Initially Estimated, Says FDA
The FDA clarified that the risk of cancer associated with exposure to nitrosamine impurities was likely lower than what was initially assessed.
Next post in General Oncology
